Aura Biosciences Inc (AURA)

Finanzdaten der Aura Biosciences Inc-Aktie (AURA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	9.97%30.75	27.96	21.90	22.18	22.88
Research and Development	9.97%30.75	27.96	21.90	22.18	22.88
Operating Income/Loss	37.87%-48.07	-34.87	-27.24	-27.91	-28.61
	106.46%2.46	1.19	1.69	1.80	1.64
Interest Income/Expense After Provision For Losses	93.87%2.31	1.19	1.54	1.82	1.68
Income/Loss From Continuing Operations Before Tax	35.44%-45.61	-33.67	-25.54	-26.10	-27.02
Income Tax Expense/Benefit	163.64%0.03	0.01	0.02	0.03	0.05
	35.48%-45.64	-33.69	-25.56	-26.13	-27.02
Attributable To Parent	35.48%-45.64	-33.69	-25.56	-26.13	-27.02
Basic Average Shares	40.65%94.86	67.45	-	65.94	58.02
Diluted Average Shares	40.65%94.86	67.45	-	65.94	58.02
Basic Earnings Per Share	4.00%-0.48	-0.50	-	-0.40	-0.47
Diluted Earnings Per Share	4.00%-0.48	-0.50	-	-0.40	-0.47